Cardiff Oncology Secures Patent for Breakthrough mCRC Treatment Amid Financial Volatility
Cardiff Oncology, Inc. is a biotech company making significant strides in cancer treatment, with a recent patent for a groundbreaking metastatic colorectal cancer treatment, but faces financial challenges in translating its innovation into success.
3 minutes to read